These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3259900)

  • 1. Continuous infusion 5-fluorouracil and folinic acid in disseminated colorectal cancer.
    Mortimer JE; Higano C
    Cancer Invest; 1988; 6(2):129-32. PubMed ID: 3259900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: an effective second-line regimen.
    Streit M; Jaehde U; Stremetzne S; Ridwelski K; Kerz H; Strohbach F; Hohenberger P; Zwiebel FM; Hebart H; Böthig R; Kairies M; Zillig D; Schuchmann S; Warnecke S; Thiel E; Kreuser ED
    Ann Oncol; 1997 Nov; 8(11):163-5. PubMed ID: 9426339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose folinic acid and 5-fluorouracil in advanced colorectal cancer.
    Di Costanzo F; Bartolucci R; Padalino D; Brugia M; Buzzi F
    Cancer Invest; 1988; 6(2):133-8. PubMed ID: 3259901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous 5-fluorouracil infusion and pulse methotrexate/leucovorin for colorectal adenocarcinoma. A report of excessive toxicity.
    Hansen RM; Quebbeman EJ; Ritch PS; Frick J; Anderson T
    Am J Clin Oncol; 1987 Jun; 10(3):216-8. PubMed ID: 3496002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
    J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary analysis of a randomized comparison of 5-fluorouracil versus 5-fluorouracil and high-dose continuous-infusion folinic acid in disseminated colorectal cancer.
    Doroshow JH; Bertrand M; Newman E; Multhauf P; Leong L; Blayney D; Goldberg D; Margolin K; Carr B; Akman S
    NCI Monogr; 1987; (5):171-4. PubMed ID: 3501538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
    Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
    Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in patients with advanced colorectal cancer: Taiwan experience.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Chen WS; Jiang JK; Yen CC; Fan FS; Hsieh RK
    Jpn J Clin Oncol; 1998 Jan; 28(1):16-9. PubMed ID: 9491136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose continuous infusion folinic acid and bolus 5-fluorouracil in patients with advanced colorectal cancer: a phase II study.
    Bertrand M; Doroshow JH; Multhauf P; Blayney DW; Carr BI; Cecchi G; Goldberg D; Leong L; Margolin K; Metter G
    J Clin Oncol; 1986 Jul; 4(7):1058-61. PubMed ID: 3487626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective comparative analysis of 5FU + low-dose folinic acid vs. 5FU + high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience.
    Maroun JA; Cripps C; Goel R; Dahrouge S; Boisvert D
    Am J Clin Oncol; 1997 Aug; 20(4):387-92. PubMed ID: 9256896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
    de Gramont A; Vignoud J; Tournigand C; Louvet C; André T; Varette C; Raymond E; Moreau S; Le Bail N; Krulik M
    Eur J Cancer; 1997 Feb; 33(2):214-9. PubMed ID: 9135491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
    Rougier P; Droz JP; Ducreux M; Kac J; Spielmann M; Crespon B; Ley G; Zimmermann P; Theodore C; Chavy A
    Bull Cancer; 1983; 70(5):434-6. PubMed ID: 6607759
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of advanced colorectal cancer with folinic acid and 5-fluorouracil in combination with cisplatinum.
    Sagaster P; Essl R; Teich G; Fritz E; Wasilewski M; Umek H; Dünser E; Mascher H; Micksche M
    Eur J Cancer; 1994; 30A(9):1250-4. PubMed ID: 7999407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
    Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
    Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
    Erlichman C; Fine S; Wong A; Elhakim T
    J Clin Oncol; 1988 Mar; 6(3):469-75. PubMed ID: 3280741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
    Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
    Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
    Kollmannsberger C; Quietzsch D; Haag C; Lingenfelser T; Schroeder M; Hartmann JT; Baronius W; Hempel V; Clemens M; Kanz L; Bokemeyer C
    Br J Cancer; 2000 Aug; 83(4):458-62. PubMed ID: 10945491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.
    Petrelli NJ; Rodriguez-Bigas M; Rustum Y; Herrera L; Creaven P
    Cancer; 1993 Sep; 72(5):1543-6. PubMed ID: 8348489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy.
    Doroshow JH; Multhauf P; Leong L; Margolin K; Litchfield T; Akman S; Carr B; Bertrand M; Goldberg D; Blayney D
    J Clin Oncol; 1990 Mar; 8(3):491-501. PubMed ID: 2407810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.
    Kerr DJ; McArdle CS; Ledermann J; Taylor I; Sherlock DJ; Schlag PM; Buckels J; Mayer D; Cain D; Stephens RJ; ;
    Lancet; 2003 Feb; 361(9355):368-73. PubMed ID: 12573372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.